Home › Asset managers › Prudential/PGIM › 2025-2026 › Against the board
Two kinds of vote are listed: a board-sponsored proposal Prudential/PGIM voted AGAINST or withheld on, and a shareholder proposal it voted FOR, with the board’s recommendation on it where the filings show one. A FOR vote on a proposal the board supported, or took no position on, is listed and labelled, but it is not a vote against the board. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.
Everything Only shareholder proposals it backed
4,159 proposals.
| Company | Meeting | Proposal | Category | On the ballot from | Board recommended | Prudential/PGIM voted | Funds |
|---|---|---|---|---|---|---|---|
| 3D Systems Corporation | May 14, 2026 | The election of the nine directors named in the accompanying Proxy Statement: Vasant Padmanabhan | Director Elections | Board | AGAINST | 1 | |
| 4D Molecular Therapeutics, Inc. | June 17, 2026 | Election of three Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected: Nancy Miller-Rich | Director Elections | Board | WITHHOLD | 1 | |
| 8x8, Inc. | July 25, 2025 | To approve an amendment to the 8x8, Inc.'s 2022 Equity Incentive Plan to increase the number of shares of common stock available for issuance thereunder by 8,500,000 shares. | Compensation | Board | AGAINST | 1 | |
| A-Mark Precious Metals, Inc. | November 12, 2025 | Advisory vote on executive compensation | Say-on-Pay | Board | AGAINST | 1 | |
| A-Mark Precious Metals, Inc. | November 12, 2025 | Advisory vote on executive compensation As an advisory vote, this proposal is not binding upon A-Mark or the Board. Nevertheless, the Board's Compensation Committee, which is comprised solely of independent directors and is responsible for making decisions regarding the amount and form of compensation paid to our executive officers, will carefully consider the stockholder vote on this matter, along with other expressions of stockholder views it receives on specific policies and desirable actions. If there are a significant number of "Against" votes, we will seek to understand the concerns that influenced the vote and address them as appropriate in making future decisions affecting the executive compensation program. | Say-on-Pay | Board | AGAINST | 1 | |
| A. O. Smith Corporation | April 13, 2026 | Election of directors: Christopher L. Mapes | Director Elections | Board | WITHHOLD | 1 | |
| A. O. Smith Corporation | April 13, 2026 | Election of directors: Dr. Ilham Kadri | Director Elections | Board | WITHHOLD | 1 | |
| A. O. Smith Corporation | April 13, 2026 | Election of directors: Lois M. Martin | Director Elections | Board | WITHHOLD | 1 | |
| A10 Networks, Inc. | April 22, 2026 | To approve, on an advisory and non-binding basis, the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 1 | |
| ABIVAX | May 11, 2026 | Authority to Issue Restricted Shares | Capital Structure | Board | ABSTAIN | 1 | |
| AC Immune SA | June 11, 2026 | Approve Creation of CHF 150,000 Pool of Conditional Capital for Employee Equity Plans | Compensation | Board | AGAINST | 1 | |
| AC Immune SA | June 11, 2026 | Approve Creation of Capital Band within the Upper Limit of CHF 2.9 Million and the Lower Limit of CHF 2.2 Million with or without Exclusion of Preemptive Rights | Capital Structure | Board | AGAINST | 1 | |
| AC Immune SA | June 11, 2026 | Approve Remuneration Report (Non-Binding) | Compensation | Board | AGAINST | 1 | |
| AC Immune SA | June 11, 2026 | Approve Remuneration of Directors in the Amount of CHF 1 Million | Compensation | Board | AGAINST | 1 | |
| AC Immune SA | June 11, 2026 | Reappoint Monika Buetler as Member of the Compensation, Nomination and Corporate Governance Committee | Director Elections | Board | AGAINST | 1 | |
| AC Immune SA | June 11, 2026 | Reappoint Roy Twyman as Member of the Compensation, Nomination and Corporate Governance Committee | Director Elections | Board | AGAINST | 1 | |
| AC Immune SA | June 11, 2026 | Reelect Monika Buetler as Director | Director Elections | Board | AGAINST | 1 | |
| AC Immune SA | June 11, 2026 | Reelect Roy Twyman as Director | Director Elections | Board | AGAINST | 1 | |
| ACM Research, Inc. | June 10, 2026 | Election of Directors: Charles Pappis | Director Elections | Board | WITHHOLD | 1 | |
| ACM Research, Inc. | June 10, 2026 | Election of Directors: David H. Wang | Director Elections | Board | WITHHOLD | 1 | |
| ACM Research, Inc. | June 10, 2026 | Election of Directors: Tracy Liu | Director Elections | Board | WITHHOLD | 1 | |
| ACNB Corporation | May 5, 2026 | To elect four (4) Class 3 directors to serve for terms of three (3) years and until their successors are elected and qualified: Kimberly S. Chaney | Director Elections | Board | AGAINST | 1 | |
| ACV Auctions Inc. | May 27, 2026 | Approve, on a non-binding, advisory basis, the compensation of our Named Executive Officers. | Say-on-Pay | Board | AGAINST | 1 | |
| ACV Auctions Inc. | May 27, 2026 | Elect the two Class II directors named in this Proxy Statement: Brian Hirsch | Director Elections | Board | WITHHOLD | 1 | |
| ACV Auctions Inc. | May 27, 2026 | Elect the two Class II directors named in this Proxy Statement: Eileen Kamerick | Director Elections | Board | WITHHOLD | 1 | |
| ADOBE INC. | April 15, 2026 | Approve, on an advisory basis, the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 1 | |
| ADT Inc. | May 27, 2026 | Election of Directors To be elected for terms expiring in 2027: Danielle Tiedt | Director Elections | Board | WITHHOLD | 1 | |
| AEON CO., LTD. | May 27, 2026 | Elect Takashi Tsukamoto | Director Elections | Board | AGAINST | 1 | |
| ALPHABET INC. | June 5, 2026 | Advisory vote to approve compensation awarded to named executive officers | Say-on-Pay | Board | AGAINST | 1 | |
| AMC Entertainment Holdings, Inc. | December 10, 2025 | Say on Pay - An advisory vote to approve the compensation of named executive officers. | Say-on-Pay | Board | AGAINST | 1 | |
| AMC Global Media Inc. | June 16, 2026 | Advisory vote on Named Executive Officer compensation | Say-on-Pay | Board | AGAINST | 1 | |
| AMC Global Media Inc. | June 16, 2026 | Election of the following nominees as Directors: Carl E. Vogel | Director Elections | Board | WITHHOLD | 1 | |
| AMC Global Media Inc. | June 16, 2026 | Election of the following nominees as Directors: Debra G. Perelman | Director Elections | Board | WITHHOLD | 1 | |
| AMC Global Media Inc. | June 16, 2026 | Election of the following nominees as Directors: Matthew C. Blank | Director Elections | Board | WITHHOLD | 1 | |
| AMERICAN INTERNATIONAL GROUP, INC. | May 13, 2026 | Advisory Vote to Approve Named Executive Officer Compensation. | Say-on-Pay | Board | AGAINST | 1 | |
| AMREP Corporation | September 11, 2025 | Election of one (1) director in Class II to hold office until the 2028 annual meeting of shareholders and until his successor is elected and qualified: Robert E. Robotti | Director Elections | Board | WITHHOLD | 1 | |
| ANHEUSER-BUSCH INBEV SA | April 29, 2026 | Remuneration report: Proposed resolution: approving the remuneration report for the financial year 2025. The 2025 annual ..Due to space limits, see proxy material for full proposal. | Say-on-Pay | Board | AGAINST | 1 | |
| AON PLC | June 26, 2026 | Advisory resolution to approve the compensation of the Company's named executive officers. | Say-on-Pay | Board | AGAINST | 1 | |
| APOLLO GLOBAL MANAGEMENT, INC. | June 8, 2026 | An advisory vote to approve the compensation of AGM's named executive officers (Say on Pay); | Say-on-Pay | Board | AGAINST | 1 | |
| APPLIED DIGITAL CORPORATION | November 5, 2025 | Approve, on an advisory basis, the executive compensation of the Company's named executive officers as described in the proxy statement. | Say-on-Pay | Board | AGAINST | 1 | |
| ARGENX SE | May 6, 2026 | The 2025 remuneration report (advisory non-binding voting item) | Say-on-Pay | Board | AGAINST | 1 | |
| ARISTA NETWORKS, INC. | May 29, 2026 | Approval, on an advisory basis, of the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 1 | |
| ARKO Corp. | June 4, 2026 | Approval of a non-binding advisory resolution regarding the compensation of the Company's named executive officers. | Say-on-Pay | Board | AGAINST | 1 | |
| ARS Pharmaceuticals, Inc. | June 24, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the accompanying proxy statement. | Say-on-Pay | Board | AGAINST | 1 | |
| ARS Pharmaceuticals, Inc. | June 24, 2026 | To elect our Board of Directors' three nominees for Class III director named in the accompanying proxy statement to serve for three-year terms until the 2029 Annual Meeting of Stockholders: Saqib Islam, J.D. | Director Elections | Board | WITHHOLD | 1 | |
| AST Spacemobile, Inc. | November 21, 2025 | To approve the Amended and Restated AST SpaceMobile, Inc. 2024 Incentive Award Plan to increase the number of shares of the Company's Class A Common Stock available for issuance thereunder and to extend the term of the plan. | Compensation | Board | AGAINST | 1 | |
| ASX Limited | October 23, 2025 | Elect Anne J. Loveridge | Director Elections | Board | AGAINST | 1 | |
| AVITA Medical, Inc. | June 3, 2026 | To approve, on an advisory basis, the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 1 | |
| Abivax SA | May 11, 2026 | Approve Compensation Report | Compensation | Board | AGAINST | 1 | |
| Abivax SA | May 11, 2026 | Approve Compensation Report of Corporate Officers | Compensation | Board | AGAINST | 1 | |
| Abivax SA | May 11, 2026 | Approve Compensation of Marc de Garidel, CEO | Say-on-Pay | Board | AGAINST | 1 | |
| Abivax SA | May 11, 2026 | Approve Compensation of Sylvie Gregoire, Chairwoman of the Board | Say-on-Pay | Board | AGAINST | 1 | |
| Abivax SA | May 11, 2026 | Approve Issuance of Equity or Equity-Linked Securities Reserved for Specific Beneficiaries, up to Aggregate Nominal Amount of EUR 750,000 | Capital Structure | Board | AGAINST | 1 | |
| Abivax SA | May 11, 2026 | Approve Issuance of Equity or Equity-Linked Securities for Qualified Investors, up to Aggregate Nominal Amount of EUR 237,873.56 | Capital Structure | Board | AGAINST | 1 | |
| Abivax SA | May 11, 2026 | Approve Issuance of Warrants (Bons) Reserved for Services Providers, Consultants, Employees and Executives, up to 10 Percent of Issued Share Capital | Compensation | Board | AGAINST | 1 | |
| Abivax SA | May 11, 2026 | Approve Remuneration Policy of CEO | Compensation | Board | AGAINST | 1 | |
| Abivax SA | May 11, 2026 | Approve Remuneration Policy of Chairwoman of the Board | Compensation | Board | AGAINST | 1 | |
| Abivax SA | May 11, 2026 | Authorize Board to Increase Capital in the Event of Additional Demand Related to Delegation Submitted to Shareholder Vote Above | Capital Structure | Board | AGAINST | 1 | |
| Abivax SA | May 11, 2026 | Authorize Capital Increase of Up to EUR 750,000 for Future Exchange Offers | Capital Structure | Board | AGAINST | 1 | |
| Abivax SA | May 11, 2026 | Authorize Capital Increase of up to 20 Percent of Issued Capital for Contributions in Kind | Capital Structure | Board | AGAINST | 1 | |
| Abivax SA | May 11, 2026 | Authorize Capital Issuances for Use in Employee Stock Purchase Plans | Compensation | Board | AGAINST | 1 | |
| Abivax SA | May 11, 2026 | Authorize Issuance of Equity or Equity-Linked Securities with Preemptive Rights up to Aggregate Nominal Amount of EUR 750,000 | Capital Structure | Board | AGAINST | 1 | |
| Abivax SA | May 11, 2026 | Authorize Issuance of Equity or Equity-Linked Securities without Preemptive Rights up to Aggregate Nominal Amount of EUR 750,000 | Capital Structure | Board | AGAINST | 1 | |
| Abivax SA | May 11, 2026 | Authorize Repurchase of Up to 10 Percent of Issued Share Capital | Capital Structure | Board | AGAINST | 1 | |
| Abivax SA | May 11, 2026 | Authorize up to 10 Percent of Issued Capital for Use in Restricted Stock Plans | Compensation | Board | AGAINST | 1 | |
| Abivax SA | May 11, 2026 | Authorize up to 10 Percent of Issued Capital for Use in Stock Option Plans | Compensation | Board | AGAINST | 1 | |
| Abivax SA | May 11, 2026 | Reelect June Lee as Director | Director Elections | Board | AGAINST | 1 | |
| Abivax SA | May 11, 2026 | Reelect Sylvie Gregoire as Director | Director Elections | Board | AGAINST | 1 | |
| Abivax SA | May 11, 2026 | Reelect Troy Ignelzi as Director | Director Elections | Board | AGAINST | 1 | |
| Absa Group Limited | June 2, 2026 | Elect Brian Kennedy | Director Elections | Board | AGAINST | 1 | |
| Absa Group Limited | June 2, 2026 | General Authority to Issue Shares | Capital Structure | Board | AGAINST | 1 | |
| Absa Group Limited | June 2, 2026 | Re-elect Fulvio Tonelli | Director Elections | Board | AGAINST | 1 | |
| Absci Corporation | June 4, 2026 | The election of the Class II directors nominated by the Board of Directors and named in our Proxy Statement to hold office for a three-year term expiring at our 2029 Annual Meeting of Stockholders or until their respective successors have been duly elected and qualified: Prof Sir Menelas Pangalos, Ph.D. | Director Elections | Board | WITHHOLD | 1 | |
| Acadian Asset Management Inc. | June 11, 2026 | Approval of 2026 Equity Incentive Plan. | Compensation | Board | AGAINST | 1 | |
| Acadian Asset Management Inc. | June 11, 2026 | Election of Directors: Andrew Kim | Director Elections | Board | AGAINST | 1 | |
| Accendra Health, Inc. | May 14, 2026 | Non-binding advisory vote to approve the compensation of the Company's named executive officers. | Say-on-Pay | Board | AGAINST | 1 | |
| Aclaris Therapeutics, Inc. | June 4, 2026 | Election of Directors: Anand Mehra, M.D. | Director Elections | Board | WITHHOLD | 1 | |
| Aclaris Therapeutics, Inc. | June 4, 2026 | Election of Directors: Maxine Gowen, Ph.D. | Director Elections | Board | WITHHOLD | 1 | |
| Aclaris Therapeutics, Inc. | June 4, 2026 | To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement accompanying the proxy card. | Say-on-Pay | Board | AGAINST | 1 | |
| Acme United Corporation | April 27, 2026 | Approval of an amendment to the 2022 Employee Stock Option Plan to increase the number of shares authorized for issuance as described in the Proxy Statement. | Compensation | Board | AGAINST | 1 | |
| Acme United Corporation | April 27, 2026 | Election of Directors: Richmond Y. Holden, Jr. | Director Elections | Board | WITHHOLD | 1 | |
| Acushnet Holdings Corp. | June 8, 2026 | Election of the following nominees for director: David Maher | Director Elections | Board | WITHHOLD | 1 | |
| Acushnet Holdings Corp. | June 8, 2026 | Election of the following nominees for director: Ho Yeon (Aaron) Lee | Director Elections | Board | WITHHOLD | 1 | |
| Acushnet Holdings Corp. | June 8, 2026 | Election of the following nominees for director: Keun Chang (Kevin) Yoon | Director Elections | Board | WITHHOLD | 1 | |
| Acushnet Holdings Corp. | June 8, 2026 | Election of the following nominees for director: Yoon Soo (Gene) Yoon | Director Elections | Board | WITHHOLD | 1 | |
| Advanced Energy Industries, Inc. | May 7, 2026 | Approval of the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan; and | Compensation | Board | AGAINST | 1 | |
| Advanced Energy Industries, Inc. | May 7, 2026 | Election of ten (10) directors: John A. Roush | Director Elections | Board | WITHHOLD | 1 | |
| Advantage Solutions Inc. | May 27, 2026 | To approve, on an advisory (non-binding) basis, the compensation of the Advantage Solutions Inc.'s named executive officers. | Say-on-Pay | Board | AGAINST | 1 | |
| Advantage Solutions Inc. | May 27, 2026 | To elect four Class III directors from the nominees described in the proxy statement: Tiffany Han | Director Elections | Board | WITHHOLD | 1 | |
| Adyen N.V. | May 28, 2026 | Authority to Suppress Preemptive Rights | Capital Structure | Board | AGAINST | 1 | |
| Aebi Schmidt Holding AG | May 21, 2026 | Election of Barend Fruithof as the Chair of the Board of Directors | Director Elections | Board | AGAINST | 1 | |
| Aehr Test Systems | October 20, 2025 | Proposal to approve an amendment to the Company's 2023 Equity Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder by an additional 2,500,000 shares of common stock | Compensation | Board | AGAINST | 1 | |
| Aeroports de Paris SA | May 21, 2026 | Authority to Issue Shares and Convertible Debt Through Private Placement | Capital Structure | Board | AGAINST | 1 | |
| Aeroports de Paris SA | May 21, 2026 | Authority to Issue Shares and Convertible Debt w/o Preemptive Rights | Capital Structure | Board | AGAINST | 1 | |
| Agenus Inc. | June 16, 2026 | To approve, in a non-binding advisory vote, the compensation of the Company's named executive officers for 2025 (Say-on-Pay). | Say-on-Pay | Board | AGAINST | 1 | |
| Airgain, Inc. | June 10, 2026 | To approve the amendment and restatement of the 2016 Incentive Award Plan. | Compensation | Board | AGAINST | 1 | |
| Airgain, Inc. | June 10, 2026 | To consider and vote upon, on an advisory basis, the compensation of our named executive officers as disclosed in this proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission. | Say-on-Pay | Board | AGAINST | 1 | |
| Airgain, Inc. | June 10, 2026 | To elect two directors to serve as Class I directors for a three-year term to expire at the 2029 annual meeting of stockholders: James K. Sims | Director Elections | Board | WITHHOLD | 1 | |
| Akbank T.A.S | March 24, 2026 | Election of Directors; Board Term Length | Director Elections | Board | AGAINST | 1 | |
| Akebia Therapeutics, Inc. | June 17, 2026 | Election of three Class III Directors to serve until the Company's 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified, subject to their earlier death, resignation or removal: Adrian Adams | Director Elections | Board | WITHHOLD | 1 |
← Previous Page 17 of 42 Next →
← Back to Prudential/PGIM 2025-2026 overview
Built October 13, 2026 from SEC Form N-PX filings.